Format

Send to

Choose Destination
JAMA Intern Med. 2014 Oct;174(10):1543-4. doi: 10.1001/jamainternmed.2014.4547.

Proposed US Food and Drug Administration guidance for industry on distributing medical publications about the risks of prescription drugs and biological products: a misguided approach.

Author information

1
Public Citizen's Health Research Group, Washington, DC.
PMID:
25127222
DOI:
10.1001/jamainternmed.2014.4547
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center